glp 1 drugs and hair loss GLP-1 Medications Loss: What You Need to Know – Theradome Glucagon-like peptide-1 receptor agonists (GLP-1RAs)
Description
The three glucose-lowering medications are common second-line therapies recommended by the guidelines [8, 9]
But we all need to work together to improve the accessibility of these drugs to our patients
doi: 10.1210/clinem/dgaa863 Summary Keywords obesity, insulin-resistance, Tirzepatide, pathophysiology, GIP, GLP - 1, clinical trials, arterial hypertension Citation Corrao S, Pollicino C, Maggio D, Torres A and Argano C (2024) Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence

Lancet 394(10213):20122024

While recognized for its leadership in metabolic health, Pendulum is advancing broader applications of the microbiome to unlock new possibilities in preventive and therapeutic care
